Report Detail
Global Fenofibrate Market Professional Survey Report 2019
- RnM3760497 |
- 18 September, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Fenofibrate, marketed as Tricor and under several other brand names, is a drug of the fibrate class. It is mainly used to reduce cholesterol levels in people at risk of cardiovascular disease. Like other fibrates, it reduces both low-density lipoprotein (LDL) and very low density lipoprotein (VLDL) levels, as well as increasing high-density lipoprotein (HDL) levels and reducing triglyceride levels.
The global Fenofibrate market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Fenofibrate volume and value at global level, regional level and company level. From a global perspective, this report represents overall Fenofibrate market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Fenofibrate in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Fenofibrate manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
AbbVie
Lupin
Salix Pharmaceuticals
Vectura
Cipher Pharmaceuticals
Rhodes Pharmaceuticals
Impax Laboratories
Mylan
Teva
Sun Pharmaceutical
Bausch Health
HETERO
Aurobindo Pharma
Cipla
Amneal Pharmaceuticals
Prinston Pharmaceutical
Dr. Reddys Laboratories
APOTEX
Glenmark
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Tablet
Capsule
Segment by Application
Hospital
Drug store
Table of Contents
Executive Summary
1 Industry Overview of Fenofibrate
- 1.1 Definition of Fenofibrate
- 1.2 Fenofibrate Segment by Type
- 1.2.1 Global Fenofibrate Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Tablet
- 1.2.3 Capsule
- 1.3 Fenofibrate Segment by Applications
- 1.3.1 Global Fenofibrate Consumption Comparison by Applications (2014-2025)
- 1.3.2 Hospital
- 1.3.3 Drug store
- 1.4 Global Fenofibrate Overall Market
- 1.4.1 Global Fenofibrate Revenue (2014-2025)
- 1.4.2 Global Fenofibrate Production (2014-2025)
- 1.4.3 North America Fenofibrate Status and Prospect (2014-2025)
- 1.4.4 Europe Fenofibrate Status and Prospect (2014-2025)
- 1.4.5 China Fenofibrate Status and Prospect (2014-2025)
- 1.4.6 Japan Fenofibrate Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Fenofibrate Status and Prospect (2014-2025)
- 1.4.8 India Fenofibrate Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Fenofibrate
- 2.3 Manufacturing Process Analysis of Fenofibrate
- 2.4 Industry Chain Structure of Fenofibrate
3 Development and Manufacturing Plants Analysis of Fenofibrate
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Fenofibrate Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Fenofibrate
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Fenofibrate Production and Capacity Analysis
- 4.2 Fenofibrate Revenue Analysis
- 4.3 Fenofibrate Price Analysis
- 4.4 Market Concentration Degree
5 Fenofibrate Regional Market Analysis
- 5.1 Fenofibrate Production by Regions
- 5.1.1 Global Fenofibrate Production by Regions
- 5.1.2 Global Fenofibrate Revenue by Regions
- 5.2 Fenofibrate Consumption by Regions
- 5.3 North America Fenofibrate Market Analysis
- 5.3.1 North America Fenofibrate Production
- 5.3.2 North America Fenofibrate Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Fenofibrate Import and Export
- 5.4 Europe Fenofibrate Market Analysis
- 5.4.1 Europe Fenofibrate Production
- 5.4.2 Europe Fenofibrate Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Fenofibrate Import and Export
- 5.5 China Fenofibrate Market Analysis
- 5.5.1 China Fenofibrate Production
- 5.5.2 China Fenofibrate Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Fenofibrate Import and Export
- 5.6 Japan Fenofibrate Market Analysis
- 5.6.1 Japan Fenofibrate Production
- 5.6.2 Japan Fenofibrate Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Fenofibrate Import and Export
- 5.7 Southeast Asia Fenofibrate Market Analysis
- 5.7.1 Southeast Asia Fenofibrate Production
- 5.7.2 Southeast Asia Fenofibrate Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Fenofibrate Import and Export
- 5.8 India Fenofibrate Market Analysis
- 5.8.1 India Fenofibrate Production
- 5.8.2 India Fenofibrate Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Fenofibrate Import and Export
6 Fenofibrate Segment Market Analysis (by Type)
- 6.1 Global Fenofibrate Production by Type
- 6.2 Global Fenofibrate Revenue by Type
- 6.3 Fenofibrate Price by Type
7 Fenofibrate Segment Market Analysis (by Application)
- 7.1 Global Fenofibrate Consumption by Application
- 7.2 Global Fenofibrate Consumption Market Share by Application (2014-2019)
8 Fenofibrate Major Manufacturers Analysis
- 8.1 AbbVie
- 8.1.1 AbbVie Fenofibrate Production Sites and Area Served
- 8.1.2 AbbVie Product Introduction, Application and Specification
- 8.1.3 AbbVie Fenofibrate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 Lupin
- 8.2.1 Lupin Fenofibrate Production Sites and Area Served
- 8.2.2 Lupin Product Introduction, Application and Specification
- 8.2.3 Lupin Fenofibrate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Salix Pharmaceuticals
- 8.3.1 Salix Pharmaceuticals Fenofibrate Production Sites and Area Served
- 8.3.2 Salix Pharmaceuticals Product Introduction, Application and Specification
- 8.3.3 Salix Pharmaceuticals Fenofibrate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Vectura
- 8.4.1 Vectura Fenofibrate Production Sites and Area Served
- 8.4.2 Vectura Product Introduction, Application and Specification
- 8.4.3 Vectura Fenofibrate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Cipher Pharmaceuticals
- 8.5.1 Cipher Pharmaceuticals Fenofibrate Production Sites and Area Served
- 8.5.2 Cipher Pharmaceuticals Product Introduction, Application and Specification
- 8.5.3 Cipher Pharmaceuticals Fenofibrate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Rhodes Pharmaceuticals
- 8.6.1 Rhodes Pharmaceuticals Fenofibrate Production Sites and Area Served
- 8.6.2 Rhodes Pharmaceuticals Product Introduction, Application and Specification
- 8.6.3 Rhodes Pharmaceuticals Fenofibrate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Impax Laboratories
- 8.7.1 Impax Laboratories Fenofibrate Production Sites and Area Served
- 8.7.2 Impax Laboratories Product Introduction, Application and Specification
- 8.7.3 Impax Laboratories Fenofibrate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Mylan
- 8.8.1 Mylan Fenofibrate Production Sites and Area Served
- 8.8.2 Mylan Product Introduction, Application and Specification
- 8.8.3 Mylan Fenofibrate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Teva
- 8.9.1 Teva Fenofibrate Production Sites and Area Served
- 8.9.2 Teva Product Introduction, Application and Specification
- 8.9.3 Teva Fenofibrate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Sun Pharmaceutical
- 8.10.1 Sun Pharmaceutical Fenofibrate Production Sites and Area Served
- 8.10.2 Sun Pharmaceutical Product Introduction, Application and Specification
- 8.10.3 Sun Pharmaceutical Fenofibrate Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 Bausch Health
- 8.12 HETERO
- 8.13 Aurobindo Pharma
- 8.14 Cipla
- 8.15 Amneal Pharmaceuticals
- 8.16 Prinston Pharmaceutical
- 8.17 Dr. Reddys Laboratories
- 8.18 APOTEX
- 8.19 Glenmark
9 Development Trend of Analysis of Fenofibrate Market
- 9.1 Global Fenofibrate Market Trend Analysis
- 9.1.1 Global Fenofibrate Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Fenofibrate Regional Market Trend
- 9.2.1 North America Fenofibrate Forecast 2019-2025
- 9.2.2 Europe Fenofibrate Forecast 2019-2025
- 9.2.3 China Fenofibrate Forecast 2019-2025
- 9.2.4 Japan Fenofibrate Forecast 2019-2025
- 9.2.5 Southeast Asia Fenofibrate Forecast 2019-2025
- 9.2.6 India Fenofibrate Forecast 2019-2025
- 9.3 Fenofibrate Market Trend (Product Type)
- 9.4 Fenofibrate Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Fenofibrate Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Fenofibrate . Industry analysis & Market Report on Fenofibrate is a syndicated market report, published as Global Fenofibrate Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Fenofibrate market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
